Movie Industry

Park Eun-bin’s Next Film in Four Years? … “One of the Projects I Was Offered for ‘Nam Eun-jeong’”

Production Company Says, "Yoon Yeo-jeong Will Not Appear"

Choi Hee-jae
2026-07-13 15:33:54
[E-Daily Starin Choi Hee-jae Reporter] Actress Park Eun-bin has been offered a role in the film "Nam Eun-jeong."
Park Eun-bin (Photo = E-Daily DB)

On the 13th, Park Eun-bin’s agency, Namu Actors, told E-Daily regarding her potential appearance in the film “Nam Eun-jeong,” “It is one of the projects actress Park Eun-bin has been offered,” adding, “Nothing has been decided yet.”
The production company confirmed, “It is true that we offered the role to Park Eun-bin, and she is currently considering it.” Regarding rumors that Yoon Yeo-jeong was also being considered for the role, they clarified, “It is true that we approached her, but she will not be appearing in the film.”
On the same day, the film industry outlet MaxMovie reported that actresses Yoon Yeo-jeong and Park Eun-bin would star in “Nam Eun-jeong,” the directorial debut of newcomer Kim Dong-hoon. “Nam Eun-jeong” is reportedly set to begin filming sometime next month.
Park Eun-bin left a strong impression in 2022 when she starred as Kyung-hee in the film *The Witch 2*. In 2023, she made a special appearance in *1947 Boston*, and in 2024, she released her fan concert *Eunbin Note: Diva* in theaters.
With her upcoming appearance in the tvN Saturday-Sunday drama “Creepy Romance,” which premieres on the 18th, anticipation is building for Park Eun-bin’s next project.

Economy

Corporation

IT·Science

Economy

Samsung DX Union Holds Long-Term Protest in Front of Jay Y. Lee’s Residence… “Close the Compensation Gap”

“Donghaeng,” a labor union composed primarily of employees from SamsungElectronics’ Device Experience (DX) Division, is holding a rally in front of Jay Y. Lee’s residence to demand the elimination of …
2026-09-05 14:21:39

Corporation

SK BIOPHARMACEUTICALS’s $400 Million Gamble… A Bigger Picture Than ‘A Second Excofry’ [Invest Bio]

SK BIOPHARMACEUTICALS(326030)is attributing significance beyond that of a mere follow-up pipeline to Opakalim (BHV-7000), a new epilepsy drug candidate it acquired from the U.S.-based Biohaven. It is …
2026-09-05 06:01:02

IT·Science

GC Wellbeing and JW Pharmaceutical Rally [K-bio Pulse]

South Korea’s pharmaceutical and biotech sector experienced significant volatility on August 13, driven by growth themes in obesity/medical aesthetics, hair loss, and immuno-oncology. #GCWellbeing sur…
2026-09-05 08:02:02